The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Devices)·Z-0921-2025·Announced 2025-01-22

DRG:HYBRiD-XL Insulin Device Recalled for Calibration Failures

DRG International is recalling the DRG:HYBRiD-XL Insulin device (Model HYE-5361) due to calibration failures and out-of-specification controls that may delay assay results.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This FDA Class II recall involves a diagnostic device with calibration and control specification failures. No patient illnesses or injuries have been reported. The stated consequence is delay in test results, which constitutes a precautionary operational issue rather than demonstrated safety harm.

Plain-English summary

DRG International, Inc. is recalling the DRG:HYBRiD-XL Insulin device, Model HYE-5361, Lot Number 429K084-1. This is a medical device used in laboratory settings for insulin assays.

The device may experience calibration failures during re-calibration using the instrument's R1 and R2 calibration controls. Users may receive a failure message during re-calibration, or they may observe that control levels fall out of specification—specifically, the Control High fails. These issues cause a delay in obtaining assay results.

The affected device has been distributed nationwide in New Jersey and internationally in Czechia and Romania.

Users of the DRG:HYBRiD-XL Insulin device with Lot Number 429K084-1 should contact DRG International, Inc. for instructions regarding the recalled device.

The recalled product

Product
DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361
Affected units
10

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • UDI: (01)04048474053616(17)20251130(10)429K084-1. Lot Number: 429K084-1

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Same manufacturer · DRG International, Inc.

See all →

Similar recalls